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INTRODUCTION
Acute renal failure (ARF) caused by ischemia or nephrotox-
ins involves both vascular and tubular events, and vascular
ischemia is considered a major contributor to radiocontrast-
induced nephropathy (RCIN) (1). Direct tubular toxicity
caused by contrast medium has also been postulated to have
a role in the induction of RCIN (1). Moreover, ARF follow-
ing contrast administration for enhanced imaging is an infre-
quent but serious imaging-associated complication. 
Two forms of cell death occur in ischemic renal injury, i.e.,
apoptosis and necrosis. Renal tubular epithelial cell injury
resulting from renal ischemia is generally regarded to be the
result of necrotic cell death. And, recently it has become clear
that apoptosis has an important role in renal tubular injury
(2, 3). Thus, apoptosis is being increasingly recognized a ma-
jor mode of cell damage after ischemic injury to the kidney
(4). Moreover, therapeutic interventions that inhibit or pro-
mote the apoptosis of renal tubular cells have the potential
to minimize renal dysfunction and accelerate recovery after
ARF (5, 6). The degree of renal apoptosis is a reflection of
renal damage caused by renal injury and is dependent on
both the nature and the severity of an insult (5). 
Computed tomographic (CT) contrast medium adminis-
tration is avoided in cases of poor renal function, especially
in patients with an ARF status, whereas magnetic resonance
(MR) imaging is used for renal imaging in both patients and
experimental animals, especially in those with an ARF status
(7-9). Thus, CT scanning is usually performed without con-
trast medium in patients with renal disease or ARF, because
the CT contrast medium aggravates renal function and occa-
sionally causes RCIN. On the other hand, MR imaging is safe
in renal disease patients and can also be used to evaluate dyna-
mic physiologic processes (9, 10). We hypothesized that a CT
contrast medium injection in an ARF model would not agg-
ravate renal damage more than MR contrast medium, and
that might offer a means of obtaining good renal images. 
Thus, we undertook this study is to compare the renal dam-
age induced by iodinated contrast and gadolinium in an ARF
rat model by monitoring serum creatinine levels and degrees
of apoptosis. 
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Comparison of Renal Damage by Iodinated Contrast or Gadolinium in
an Acute Renal Failure Rat Model Based on Serum Creatinine Levels
and Apoptosis Degree
This study was undertaken to compare renal damage, as determined by serum
creatinine and degree of apoptosis, caused by iodinated contrast or gadolinium in
an acute renal failure (ARF) rat model. Rats were divided into three groups; con-
trols (n=3), a CT contrast medium group (n=9), and an MR contrast medium group
(n=9). The CT and MR groups were further subdivided into three groups, namely,
low, standard, and high dose subgroups. Renal function was evaluated by deter-
mining serum creatinine levels; before ARF, and 48 hr after ARF and contrast
administration. Apoptosis was assayed by terminal deoxynucleotidyl transferase-
mediated dUTP nick-end labeling (TUNEL). No significant creatinine level differ-
ences were observed between the CT and MR groups (p=0.116). Degrees of
apoptosis in the renal cortex and medulla were more severe in the CT contrast
medium group than in the control or MR contrast medium group (p<0.05). The
study shows that CT contrast medium did not aggravate renal function more so
than MR contrast medium in this ARF rat model. However, apoptosis examination
in the renal cortex and medulla indicated that CT contrast medium induced more
severe apoptosis than MR contrast medium (p<0.05). We conclude that CT con-
trast medium can be used for renal imaging studies when subjects are well hydrat-
ed and preventive medication is administered.
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MATERIALS AND METHODS
Rat acute renal failure model 
Animal experiments were conducted according to the Na-
tional Institute of Health’s Guide for the Care and use of
Laboratory Animals (NIH publication No. 80-23, revised
in 1996). The acute renal failure rat model was constructed
as described previously (11). Briefly, male and non-pregnant
female Sprague-Dawley rats, weighing 250-300 g, were ob-
tained from our breeding colony. Abdominal cavities were
opened via a midline incision after anesthetization with a
0.1 mL/100 mg mixture of ketamine and xylazine [9 ketamine
(30 mg/kg of body weight, I.M.): 1 xylazine (5 mg/kg of
body weight, I.M.)]. Both renal pedicles were then exposed
and cleaned by blunt dissection. Microvascular clamps were
placed on both the renal artery and vein to completely block
renal blood flow. Core body temperature was maintained at
37℃ by placing animals on a homeothermic table and was
monitored with a temperature-sensing rectal probe. A prelim-
inary experiment indicated that renal injury induced by occlu-
sion with reperfusion after 45 min was optimal. Thus, after
45 min, clamps were removed and blood flow reestablished
(12). If reperfusion was found by visual inspection to be incom-
plete, the experiment was terminated and particular animal
sacrificed. Control animals were administered the same anesthet-
ics and underwent the same midline an abdominal incisions,
and had both renal arteries and veins cleaned and only placed
in contact with microvascular clamps for 45 min before the
incision was closed (11). After completing surgery and anes-
thetic recovery, animals were returned to their metabolic cages
and fed a normal diet. All rats were sacrificed 96 hr after ARF
using a 0.4 mL/100 mg mixture of ketamine and xylazine [9
ketamine (30 mg/kg of body weight, I.M.): 1 xylazine (5 mg/
kg of body weight, I.M.)]. 
ARF was defined as a two-fold increase in creatinine level
from pre-ARF to 48 hr after ARF. Renal function changes
were assessed by measuring serum creatinine concentrations
at each experimental time point (pre ARF, post 48 hr ARF,
and 48 hr after contrast injection in ARF). Creatinine concen-
trations were measured using an Autoanalyzer (Hitachi 747,
Tokyo, Japan) and blood sampled from a rat tail vein using
a 24-gauge intravenous catheter (Green-Cross Co., Yong-In,
Korea) under same anesthesia. Contrast was injected via a tail
vein using a 24-guage intravenous catheter. Blood sampling
was performed before ARF, 48 hr after ARF, and then 48 hr
after contrast injection in ARF (96 hr after ARF). 
Rats were divided into a control group (n=3), a CT group
(n=9), and an MR group (n=9). The CT and MR groups were
further subdivided into three subgroups based on clinical do-
sage, i.e., low-dose (CT: 0.5 mL/kg=0.15 g iodine/kg, MR:
0.2 mL/kg=0.1 mM/kg), standard (CT: 2 mL/kg=0.6 g io-
dine/kg, MR: 0.8 mL/kg=0.4 mM/kg), and high-dose (CT:
8 mL/kg=2.4 g iodine/kg, MR: 3.2 mL/kg=1.6 mM/kg) (7).
The contrast medium used was Ultravist
� (Korea Schering,
Seoul, Korea) in the CT group and Magnevist
� (Gd-DTPA,
Schering AG, Allemagne, Germany) in the MR group.
Terminal deoxynucleotidyl transferase-mediated dUTP
nick-end labeling (TUNNEL) assay
At the end of the study, a midline incision was made in the
abdomen of each rat to expose of the aorta and inferior vena
cava. For both kidneys in each animal supra- and infra-renal
abdominal aortas were clamped using microvascular clamps,
inferior vena cava were dissected, and kidneys were perfused
with phosphate buffered saline through the aorta. Both kid-
neys were removed, fixed with formalin for two hours, and
embedded in paraffin. Samples were washed for 3×5 min in
xylene, 2×5 min in absolute ethanol, once in 95% ethanol
for 3 min, once in 70% ethanol for 3 min, and once in phos-
phate buffered saline for 5 min. Tissues were then pretreated
with freshly diluted proteinase K (Proteinase K, Dako) for
15 min at room temperature on the slide, and endogenous
peroxidase were quenched by treating with 3% hydrogen per-
oxide in phosphate buffered saline 5 min. Equilibration buffer
was then applied to slides, which were then incubated with
terminal deoxynucleotidyl transferase for 1 hr at 37℃. Slide
were then placed in the anti-digoxigenin peroxidase conju-
gate for 30 min at room temperature. To develop color, suf-
ficient peroxidase substrate was applied to specimens, which
were then counterstained with 0.5% methyl green for 10 min
and mounted. Apoptosis was detected using the Apoptag
Plus Peroxidase In Situ Apoptosis Detection Kit (Intergen,
NY, U.S.A.), as previously described (13). This method de-
tects the DNA fragmentation associated with apoptosis by
labeling 3′ -OH DNA termini with digoxigenin-nucleotides,
a process facilitated by terminal deoxynucleotidyl transferase
(TdT). The labeled fragments produced are then allowed to
bind to anti-digoxigenin antibody conjugated with peroxi-
dase; AEC was used as a peroxidase substrate. Specimens were
counter-stained with hematoxylin. Two independent inves-
tigators unaware of the experimental conditions counted
apoptotic cells in 15 microscopic fields in the renal cortex,
outer medulla or inner medulla under a light microscope at
×100; the determined inter-investigator variation was <5%.
Numbers of apoptotic cells are expressed as cell numbers in
each field; value represent mean value determined for 15 fields
from each of the six experimental conditions and the control.
Statistical analysis 
Data are presented as means±SD. Degrees of apoptosis
were compared 48 hr after contrast injection (96 hr after
ARF) using one-way ANOVA which was used SPSS ver.
10.0 for Windows. Change in creatinine levels at 48 hr and
96 hr after ARF were analyzed statistically using the Wilcox-
on signed-rank test.RESULTS
Creatinine ratios versus the control at 48 and 96 hr post-
ARF in the CT subgroups were 2.45 and 3.16 in the low
dose subgroup; 2.03 and 2.01 in the standard dose subgroup;
and 1.76 and 1.79 in high dose subgroup, respectively. Simi-
larly, creatinine ratios in the MR subgroups were 1.52 and
1.34 (low dose); 2.13 and 1.58 (standard dose); and 1.81 and
1.39 (high dose) (Table 1). No significant difference was ob-
served between the creatinine levels of the CT and MR groups
(p=0.116) 48 and 96 hr post-ARF. In addition, contrast dose
levels were found to have similar effects on creatinine levels
in the CT and MR groups (Table 2) (Fig. 1). 
The CT group showed a slight increase in the number of
scattered apoptotic cells in the cortex and medulla. The con-
trol group showed 18±0.8 apoptotic cells/×100 filed in the
cortex and 12±2.8 in the medulla (Table 2). The low dose
CT subgroup showed significantly more apoptosis in the renal
cortex and medulla than the control group (p<0.05), where-
as the high dose CT subgroup showed severe apoptosis in the
cortex and medulla versus the low and standard CT subgroups
(Fig. 2). The MR group showed slightly more scattered apop-
totic cells in the cortex and medulla this increase was closely
related to contrast dose (Fig. 3). Moreover, the CT group
showed significantly more severe apoptosis in the cortex and
medulla than the MR group (n=18; p<0.05) (Fig. 4). The
numbers of apoptotic cells observed under the various condi-
tion used are presented in Fig. 4.
DiSCUSSION
The aim of this study was to compare renal damage, as
determined by serum creatinine and degree of apoptosis, caus-
ed by iodinated contrast or gadolinium in an acute renal fail-
ure animal model. This study shows that CT contrast medi-
um dose not aggravate renal function in ARF rats than MR
contrast medium. However, the observation of apoptosis in
the renal cortex and medulla, demonstrates that CT contrast
medium administration is associated with higher levels of
cellular damage than MR contrast medium. Thus, the present
study indicates that CT contrast medium should only be used
for renal imaging studies when patients are well hydrated
and after they have been administered preventive medications. 
ARF has been reported after contrast medium injection
and numerous theories have been proposed concerning the
mechanism involved, which vary from vascular changes and
tubular obstruction to direct contrast agent toxicity (1, 7-10,
14-16).
Several ARF animal model designs have been described;
bilateral renal artery clamping for 45 min and subsequent
release, which is similar to the model used in the present study
(11, 12); the 2-mg/kg intravenous injection of HgCl2 (1 mg/
dL) (7, 8); and the intramuscular injection of a 50% glycerol
solution (10 mL/kg) (13). ARF model with drug injection
do not provide a good animal model because they did not
evaluate the renal function with the contrast medium reaction.
The incidence of acute contrast-induced reductions in renal
function varies from 0 to 90% depending on the presence of
various risk factors, which include chronic renal insufficiency,
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48 hr after ARF
48 hr after contrast 
injection in ARF
CT group
Low 2.45 3.16
Standard 2.03 2.01
High 1.76 1.79
MR group
Low 1.52 1.34
Standard 2.13 1.58
High 1.81 1.39
Table 1. The creatinine ratios each group versus controls
Low MR CM
Standard MR CM
High MR CM
Low CT CM
Standard CT CM
High CT CM
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Fig. 1. Graph showing no significant difference in the creatinine lev-
els of the CT and MR groups (p=0.116). In addition, no significant
differences were found on changing CT or MR contrast medium do-
sages. CM, Contrast medium; ARF, Acute renal failure.
No. of apoptotic cells
Control 18.6±1.6 12.0±5.0
CT
Low dose 70.0±15.7* 549.7±268.7*
Standard dose 114.5±111.4 610.0±391.9
High dose 180.0±149.7** 1,647.3±825.9**
MR
�
Low dose 16.3±7.7 61.0±13.9
Standard dose 80.0±75.2 399.0±95.4
High dose 156.0±45.2 226.8±392.8
Table 2. Renal apoptosis in the cortex and medulla in the various
groups
Renal medulla 
(mean±SD)
Renal cortex 
(mean±SD)
*, p<0.05 vs. control; **, p<0.05 vs. standard dose or low dose; 
� , p<0.05
vs. CT (each group).844 H.-S. Kwak, Y.-H. Lee, Y.-M. Han, et al.
diabetes mellitus, and the amount of contrast agent admin-
istered (14-17). If a patient is suspicious for ARF or is in a
high-risk group for renal failure, unenhanced CT is normally
used to examine the genitourinary system, because an acute
deterioration of renal function may occur after exposure to
radiocontrast media. However, although a renal stone or cyst
can be detected by CT without radiocontrast enhancement,
renal contours and vascular-enriched masses cannot. The great-
est impact of radiocontrast nephropathy is that in severe cases
renal replacement therapy may be required, and to avoid this
risk radiologic evaluation without radiocontrast, despite its
limitations, is the current practice (7-9). On the other hand,
clinicians have been able to perform MR studies in such pa-
tients since the modality was first introduced (18). Although
gadolinium DTPA is ionic and has high-osmolarity, the re-
quired dose is small compared to the quantities of iodinated
contrast medium required for CT (8). Currently, clinicians
assumed that MR contrast media do not have adverse effects
in poor renal function patients and that they can be freely used
to evaluate renal function. Moreover, experience indicates that
the technique is both safe and effective in cases of possible
ARF and in patients at high-risk of ARF development. 
Earlier studies encouraged hydration in patients with chron-
ic renal insufficiency in order to prevent acute contrast-induced
reductions in renal function (17, 19). It has been reported
that vacuoles are formed in the proximal tubular cells in ani-
mals and humans after contrast injection (17, 19). Others
have reported that nonionic and hypo-osmolar contrast media
induced more vacuolization than the ionic, hyper-osmolar
contrast medium diatrizoate (17, 19). Moreover, MR contrast
media were found not to produce lysosomal alterations, and
gadolinium DTPA administration in an ARF model showed
no significant difference from controls (19). In the present
study, apoptosis was more severe in the CT contrast group
than in the MR contrast group (p<0.05). However, creati-
nine levels were not statistically different between these two
groups, and did not respond to dose. 
A reduction in the glomerular filtration rate (GFR) is a pri-
Fig. 2. Effect of CT contrast medium on the renal cortex and medulla. The red cells are TUNEL positive. Apoptotic degree in the renal medulla
was more severe than that in the renal cortex. CT contrast medium increased the severity of apoptosis in a high dose. CT contrast medium
induced more apoptosis in the renal cortex and medulla than MR contrast medium. (A) Cortex-control, (B) Cortex-low dose, (C) Cortex-stan-
dard dose, (D) Cortex-high dose, (E) Medulla-control, (F) Medulla-low dose, (G) Medulla-standard dose, (H) Medulla-high dose. Original
magnification ×100 (Bar; 50  m). C, Control; L, Low dose; S, Standard dose; H, High dose.
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mary characteristic of ischemic ARF in humans and animals
(20, 21), and serum creatinine levels are a good indicator of
renal insufficiency (1). Therapeutic interventions that inhibit
or promote renal tubular cell apoptosis potentially minimize
renal dysfunction and accelerate recovery after ARF (5, 6).
However, ARF and acute tubular necrosis continue to be clini-
cally frustrating entities from both the diagnostic and thera-
peutic standpoints (22). Moreover, many preventive medica-
tions with contrast have been administered in animal and clin-
ical studies. These include atrial natriuretic peptide (23), en-
dothelin receptor antagonists (24), adenosine receptor antag-
onists (25), calcium antagonists (26), furosemide, mannitol,
and dopamine-1 receptor agonist as well as inhibitors of oxy-
gen/hydroxyl radical scavengers (27-29). In the present study,
no preventive medication was administered prior to contrast
medium.
Creatinine level is a good indicator of renal function (1),
and apoptosis degree is a good indicator of renal damage (2-
6). Lieberthal et al. (30) reported that high levels of creatinine
were observed during the first phase of apoptosis in ARF (12-
Fig. 3. Effect of MR contrast medium on the renal cortex and medulla. The red cells shown are TUNEL-positive. The degree of apoptosis
observed in the renal medulla was more severe than in the renal cortex. MR contrast medium increased the severity of apoptosis in a dose-
dependent manner. (A) Cortex-control, (B) Cortex-low dose, (C) Cortex-standard dose, (D) Cortex-high dose, (E) Medulla-control, (F) Medulla-
low dose, (G) Medulla-standard dose, (H) Medulla-high dose. Original magnification ×100 (Bar, 50  m). C, Control; L, Low dose; S, Stan-
dard dose; H, High dose. 
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Fig. 4. Quantitative analysis of apoptotic cells per microscopic field
in the renal cortex and medulla. The apoptotic effects of CT and
MR contrast media were significant different (p<0.05).
*
C L SH
CLSH48 hr), and these were found to be well correlated with renal
function and the degree of renal damage. During the second
phase (the recovery phase; 5-7 days) creatinine levels were lo-
wer, which possibly contributed to injured tubule remodeling
and facilitated their return to normal structural and functional
states. However, the degree of renal apoptosis increased when
contrast medium administration, as the contrast medium was
probably toxic. 
The present study has some limitations; 1) the number of
animals used was small, 2) the rat ARF model may not well
reflect human ARF, 3) creatinine levels were not constant after
ARF and may depend on individual animal condition, 4) GFR
was not calculated because urine creatinine levels were not
measured, 5) the discrepancy between the creatinine levels
and the degree of apoptosis observed in the two groups can-
not be explained by proposed renal damage mechanism.
We conclude that CT contrast medium did not aggravate
renal function in ARF rats more than MR contrast medium.
However, based on the apoptosis observed in the renal cortex
and medulla, it is apparent that CT contrast medium admin-
istration is associated with higher levels of apoptosis than MR
contrast medium. Thus, we conclude that CT contrast medi-
um should only be used for renal imaging studies when pa-
tients are well hydrated and after they have been administered
preventive medications. 
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